SPECIFIC PHARMA A/S: Financial statements 2018
CVR: 33161395
Source: annual report 2018, Danish Business Authority
01/02/2017 – 31/01/2018
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 145,726,000 and a net result of DKK 14,821,000 compared with DKK 26,240,000 the year before. That is an increase of 2.3% compared with the year before. The profit margin was 10.2%. Equity in the 2018 report amounted to DKK 69,734,000. The solvency ratio was 79.8%. The company had 12 employees in the financial year.
- Revenue
- DKK 145,726,000
- Gross Profit
- DKK 29,736,000
- Profit/Loss
- DKK 14,821,000
- Equity
- DKK 69,734,000
- Total Assets
- DKK 87,351,000
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 145.7 mio. | 29.7 mio. | 14.8 mio. | 69.7 mio. | 12 |
| 2017 | 142.4 mio. | 41.9 mio. | 26.2 mio. | 74.6 mio. | 8 |
| 2016 | 141.1 mio. | - | 20.2 mio. | 63.5 mio. | 8 |
| 2015 | 132 mio. | 35.9 mio. | 24.1 mio. | 61.4 mio. | 4 |
| 2014 | 137.8 mio. | 30.3 mio. | 18.7 mio. | 37.3 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The board consists of Kristine Sakstrup Haag (chair), Henrik Kaastrup, Kasper Casparij Yde and Ken Rasmussen. The company is owned by NOMECO A/S. The company has 24 employees (2018). In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity in the 2026 report amounted to DKK 98,645,000.